Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeneGo, a provider of software and manually curated databases for systems biology and pathway analysis, has announced that Bayer Schering Pharma has renewed its MetaCore licenses for another three years.
Subscribe to our email newsletter
Bayer Schering Pharma has programs for cancer, cardiovascular diseases and gynecological therapies and GeneGo has good coverage of these diseases and others, said GeneGo.
GeneGo is also in the process of building disease-specific platforms in cancer and the cardiovascular area that include blueprint pathway maps for the disease, processes and mechanisms as well as offering public domain experimental data and disease ontologies.
Julie Bryant, vice president of business development at GeneGo, said: “Bayer Schering Pharma was one of our first customers and we appreciate their loyalty. MetaCore is widely used in Bayer in multiple departments including bioinformatics, oncology, cardiology and women’s health for data mining and analysis of multiple omics experimental data such as gene expression and proteomics.”